Physician profile
Curtis Prejean
NPI 1790705010
$5,242.33
in general payments reported to CMS, 2019-2025
12 companies · $639 in 2025
The $639 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $388 · 2021: $1,856 · 2022: $571 · 2023: $388 · 2024: $782 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,809.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,528.45 | 2020-2025 | Impella |
| Edwards Lifesciences Corporation | $1,781.49 | 2020-2025 | Mitris Resilia Mitral Valve, Hemosphere, Inspiris Resilia Aortic Valve |
| Medtronic Vascular, INC. | $385.06 | 2019 | |
| Endologix LLC | $134.45 | 2019-2020 | |
| Abbott Laboratories | $109.71 | 2019 | |
| Atricure, INC. | $107.00 | 2022-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Ethicon US, LLC | $75.78 | 2019-2023 | Megadyne |
| Depuy Synthes Sales INC. | $51.59 | 2021-2025 | Matrixrib |
| Imperative Care, INC | $21.31 | 2025 | Symphony Catheter |
| Kls-Martin L.P. | $18.29 | 2019 | |
| Boston Scientific Corporation | $15.63 | 2023 | Opticross 35 |
| Medtronic, INC. | $13.57 | 2023 | Endurant Iis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Curtis Prejean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.